Chemo Pharma Laboratories Ltd., specializes in Pharmaceuticals within the Healthcare sector.
Chemo Pharma Laboratories Ltd.,, with Security Code 506365, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 2024-03-31 | - | -2.91 | 2.47 | - | - | 2.47 | -0.02 | 1.52 |
2023-10-01 | 2023-12-31 | - | 6.76 | 7.02 | 4.51 | - | 7.02 | -0.02 | 6.77 |
2023-07-01 | 2023-09-30 | - | 4.39 | 4.60 | 2.93 | - | 4.60 | -0.02 | 4.39 |
2023-04-01 | 2023-06-30 | - | 3.76 | 4.29 | 2.51 | - | 4.29 | -0.02 | 3.76 |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 17% |
5 Years: | 42% |
3 Years: | 69% |
TTM: | 2300% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 53% |
3 Years: | 37% |
1 Year: | 96% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 53% |
3 Years: | 37% |
1 Year: | 96% |
Chemo Pharma Laboratories Ltd. has received approval from the United States Food and Drug Administration (USFDA) for Levofloxacin tablets in the strength of 250 mg and 500 mg.
Chemo Pharma Laboratories Ltd. has launched a new manufacturing facility in India. The facility is located in the state of Gujarat and will produce a range of pharmaceutical products.
Chemo Pharma Laboratories Ltd. has announced a partnership with a global pharmaceutical company. The partnership will focus on the development and commercialization of new drugs.